Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Do Hedge Funds Love Synopsys, Inc. (SNPS)?

Page 1 of 2

With the third-quarter round of 13F filings behind us it is time to take a look at the stocks in which some of the best money managers in the world preferred to invest or sell heading into the fourth quarter. One of these stocks was Synopsys, Inc. (NASDAQ:SNPS).

Synopsys, Inc. (NASDAQ:SNPS) was in 21 hedge funds’ portfolios at the end of September. SNPS investors should pay attention to an increase in support from the world’s most elite money managers of late. There were 19 hedge funds in our database with SNPS holdings at the end of the previous quarter. The level and the change in hedge fund popularity aren’t the only variables you need to analyze to decipher hedge funds’ perspectives. A stock may witness a boost in popularity but it may still be less popular than similarly priced stocks. That’s why at the end of this article we will examine companies such as Mobile TeleSystems OJSC (ADR) (NYSE:MBT), China Southern Airlines Co Ltd (ADR) (NYSE:ZNH), and ResMed Inc. (NYSE:RMD) to gather more data points.

Follow Synopsys Inc
Trade (SNPS) Now!

To the average investor there are a multitude of tools investors can use to value publicly traded companies. Two of the most underrated tools are hedge fund and insider trading moves. Our experts have shown that, historically, those who follow the best picks of the top fund managers can outperform their index-focused peers by a solid amount (see the details here).

With all of this in mind, we’re going to check out the key action surrounding Synopsys, Inc. (NASDAQ:SNPS).

What have hedge funds been doing with Synopsys, Inc. (NASDAQ:SNPS)?

At Q3’s end, a total of 21 of the hedge funds tracked by Insider Monkey held long positions in this stock, a change of 11% from one quarter earlier. With hedgies’ sentiment swirling, there exists an “upper tier” of noteworthy hedge fund managers who were boosting their holdings substantially (or already accumulated large positions).

According to Insider Monkey’s hedge fund database, Alkeon Capital Management, managed by Panayotis Takis Sparaggis, holds the biggest position in Synopsys, Inc. (NASDAQ:SNPS). Alkeon Capital Management has a $153.5 million position in the stock, comprising 3.2% of its 13F portfolio. On Alkeon Capital Management’s heels is AQR Capital Management, managed by Cliff Asness, which holds a $54.4 million position; 0.1% of its 13F portfolio is allocated to the stock. Some other professional money managers that hold long positions contain Ken Fisher’s Fisher Asset Management, Lee Munder’s Lee Munder Capital Group and Glenn Russell Dubin’s Highbridge Capital Management.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!